Evidence map›Paper›PMID 37720137›Full record

ArticleCureus2023

A Predictive Rule for COVID-19 Pneumonia Among COVID-19 Patients: A Classification and Regression Tree (CART) Analysis Model.

Sayato Fukui, Akihiro Inui, Takayuki Komatsu, Kanako Ogura, Yutaka Ozaki, Manabu Sugita, Mizue Saita, Daiki Kobayashi, Toshio Naito

Abstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sayato FukuiDepartment of General Medicine, Faculty of Medicine, Juntendo University, Tokyo, JPN.
Akihiro InuiDepartment of General Medicine, Faculty of Medicine, Juntendo University, Tokyo, JPN.
Takayuki KomatsuDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Tokyo, JPN.
Kanako OguraDepartment of Diagnostic Pathology, Juntendo University Nerima Hospital, Tokyo, JPN.
Yutaka OzakiDepartment of Diagnostic Radiology, Juntendo University Nerima Hospital, Tokyo, JPN.
Manabu SugitaDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Tokyo, JPN.
Mizue SaitaDepartment of General Medicine, Faculty of Medicine, Juntendo University, Tokyo, JPN.
Daiki KobayashiDepartment of General Internal Medicine, Tokyo Medical University Ibaraki Medical Center, Inashiki, JPN.
Toshio NaitoDepartment of General Medicine, Faculty of Medicine, Juntendo University, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn this study, we aimed to identify predictive factors for coronavirus disease 2019 (COVID-19) patients with complicated pneumonia and determine which COVID-19 patients should undergo computed tomography (CT) using classification and regression tree (CART) analysis.

methodsThis retrospective cross-sectional survey was conducted at a university hospital. We recruited patients diagnosed with COVID-19 between January 1 and December 31, 2020. We extracted clinical information (e.g., vital signs, symptoms, laboratory results, and CT findings) from patient records. Factors potentially predicting COVID-19 pneumonia were analyzed using Student's

resultsAmong 221 patients (119 men (53.8%); mean age, 54.59±18.61 years), 160 (72.4%) had pneumonia. The CART analysis revealed that patients were at high risk of pneumonia if they had C-reactive protein (CRP) levels of >1.60 mg/dL (incidence of pneumonia: 95.7%); CRP levels of ≤1.60 mg/dL + age >35.5 years + lactate dehydrogenase (LDH)>225.5 IU/L (incidence of pneumonia: 95.5%); and CRP levels of ≤1.60 mg/dL + age >35.5 years + LDH≤225.5 IU/L + hemoglobin ≤14.65 g/dL (incidence of pneumonia: 69.6%). The area of the curve of the receiver operating characteristic of the model was 0.860 (95% CI: 0.804-0.915), indicating sufficient explanatory power.

conclusionsThe present results are useful for deciding whether to perform CT in COVID-19 patients. High-risk patients such as those mentioned above should undergo CT.

Indexed as

blood testingclinical featurecomputed tomographyprevalent infectionsevere acute respiratory syndrome coronavirus 2

Identifiers

PMID37720137
PMCPMC10500617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.